Steven Boyd’s Armistice Capital Expands Footprint in Women’s Health Innovation and Technology
The landscape of women’s health technology investment is experiencing a notable shift, with recent data indicating growing investor confidence despite historically limited funding allocation. While femtech companies received just 2% of the $41.2 billion in healthcare venture funding during 2023, the sector demonstrates promising growth potential, according to recent Deloitte analysis. This emerging trend becomes […]
Continue Reading